Evidence map›Paper›PMID 34945041›Full record

ReviewJournal of clinical medicine2021

CSA-AKI: Incidence, Epidemiology, Clinical Outcomes, and Economic Impact.

Alan Schurle, Jay L Koyner

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Kidney Injury Following Cardiac Surgery: A Review of Our Current Understanding.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  13. Article
  14. Kidney PROTECTION after Cardiac Surgery with Intravenous Amino Acid Infusion.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alan SchurleDepartment of Anesthesia and Critical Care Medicine, University of Chicago, 5841 South Maryland Ave., MC4028, Chicago, IL 60637, USA.ORCID 0000-0002-0830-1428
Jay L KoynerSection of Nephrology, Department of Medicine, University of Chicago, 5841 South Maryland Ave., Suite S-507, MC5100, Chicago, IL 60637, USA.ORCID 0000-0001-6873-8712
University of Chicago · US

Funding

Using Machine Learning for Early Recognition and Personalized Treatment of Acute Kidney InjuryR01DK126933 · NIDDK · UNIVERSITY OF CHICAGO · PI CHURPEK, MATTHEW MICHAEL, KOYNER, JAY L · 2021 to 2025
$3.4M
NIDDK NIH HHS R01 DK126933NIH HHS R01DK126933
6 · The paper itself

Abstract

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication following cardiac surgery and reflects a complex biological combination of patient pathology, perioperative stress, and medical management. Current diagnostic criteria, though increasingly standardized, are predicated on loss of renal function (as measured by functional biomarkers of the kidney). The addition of new diagnostic injury biomarkers to clinical practice has shown promise in identifying patients at risk of renal injury earlier in their course. The accurate and timely identification of a high-risk population may allow for bundled interventions to prevent the development of CSA-AKI, but further validation of these interventions is necessary. Once the diagnosis of CSA-AKI is established, evidence-based treatment is limited to supportive care. The cost of CSA-AKI is difficult to accurately estimate, given the diverse ways in which it impacts patient outcomes, from ICU length of stay to post-hospital rehabilitation to progression to CKD and ESRD. However, with the global rise in cardiac surgery volume, these costs are large and growing.

Indexed as

acute kidney injurycardiac surgeryclinical nephrologyepidemiologymortalityoutcomesrenal replacement therapy

Identifiers

PMID34945041
PMCPMC8706363
OpenAlexW4200568122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.